JPRN-UMIN000009856
Completed
未知
To adjuvant chemotherapy after curative treatment of head and neck cancer A study of alternate-day administration definitive TS-1 - Phase II of the TS-1 every other day dosing regimen in head and neck cancer
ational Center for Global health and Medicine Otolarygology0 sites55 target enrollmentJanuary 24, 2013
ConditionsHead and neck cancer
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Head and neck cancer
- Sponsor
- ational Center for Global health and Medicine Otolarygology
- Enrollment
- 55
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)It is contraindicated in patients with the administration of TS\-1 2\)Cases that are complicated by infection requiring treatment 3\)Gastrointestinal disease with treatment (intestinal paralysis, intestinal obstruction, etc.) Patients with 4\)Patients with interstitial pneumonitis or pulmonary fibrosis 5\)Patients with diabetes 6\)Patients with heart disease 7\)Patients with (watery) diarrhea 8\)Patients attending physician was deemed inappropriate as the subject of the study for other reasons
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Outcome of patients treated with chemotherapy and Radiation in Cervical Cancer.Health Condition 1: null- Cancer of CervixCTRI/2014/06/004699A50
Completed
Phase 2
Adjuvant chemotherapy for completely rsected non-small cell lung cancer with TS-1 - evaluation of predictive factors for prognosiscompletely resected non-small cell lung cancerJPRN-UMIN000001049Division of General Thoracic Surgery, Keio University, School of Medicine,200
Active, not recruiting
Phase 1
Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastasesThe CHARISMA randomized multicenter clinical trialEUCTR2013-004952-39-NLErasmus MC Cancer Institute224
Completed
Phase 3
eo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases ;The CHARISMA randomized multicenter clinical trialLiver metastases colorectal cancer1001981510017998NL-OMON44796Erasmus MC, Universitair Medisch Centrum Rotterdam224
Not yet recruiting
Not Applicable
Chemotherapy followed by versus surgery alone in high-risk patients with colorectal liver metastasesColorectal liver metastases, clinical risk score, high risk patients, colorectale levermetastasen, klinische risico score, hoog risico patientenNL-OMON27498Prof. Dr. C. VerhoefErasmus MC Cancer Institute224